Cardinal Health, Inc. $CAH Holdings Trimmed by Kovitz Investment Group Partners LLC

Kovitz Investment Group Partners LLC reduced its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 42.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 136,024 shares of the company’s stock after selling 100,481 shares during the period. Kovitz Investment Group Partners LLC owned approximately 0.06% of Cardinal Health worth $27,953,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CAH. Redhawk Wealth Advisors Inc. grew its stake in shares of Cardinal Health by 0.5% in the 4th quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock worth $1,902,000 after purchasing an additional 48 shares during the last quarter. HF Advisory Group LLC boosted its holdings in Cardinal Health by 0.9% during the fourth quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock worth $1,074,000 after buying an additional 49 shares in the last quarter. Hillsdale Investment Management Inc. grew its position in Cardinal Health by 0.9% in the fourth quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock worth $1,184,000 after buying an additional 50 shares during the last quarter. Generali Asset Management SPA SGR increased its holdings in shares of Cardinal Health by 11.0% in the fourth quarter. Generali Asset Management SPA SGR now owns 513 shares of the company’s stock valued at $105,000 after buying an additional 51 shares in the last quarter. Finally, Stephens Inc. AR boosted its stake in shares of Cardinal Health by 0.9% during the 4th quarter. Stephens Inc. AR now owns 5,951 shares of the company’s stock worth $1,223,000 after acquiring an additional 52 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on CAH. Morgan Stanley upped their target price on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a report on Tuesday, April 28th. Leerink Partners restated an “outperform” rating and set a $275.00 price objective on shares of Cardinal Health in a report on Monday, March 9th. Evercore reduced their price objective on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th. Citigroup decreased their target price on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a report on Friday, May 1st. Finally, William Blair initiated coverage on shares of Cardinal Health in a report on Tuesday, April 28th. They set an “outperform” rating on the stock. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $246.93.

Cardinal Health Trading Down 1.9%

Shares of CAH stock opened at $222.08 on Friday. The company has a market capitalization of $52.01 billion, a price-to-earnings ratio of 33.96, a P/E/G ratio of 1.24 and a beta of 0.52. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60. The stock’s fifty day simple moving average is $204.20 and its 200-day simple moving average is $209.18.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. During the same period in the prior year, the business earned $2.35 EPS. The business’s revenue for the quarter was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio is 31.19%.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.